65 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2696

Shanghai Henlius Biotech
HK$16.600.6%21.5%HK$9.0bHK$18.03PE15.3xE15.8%n/a

1952

Everest Medicines
HK$24.951.2%72.3%HK$8.0bHK$28.05PS58.7xE80.2%n/a

2877

China Shineway Pharmaceutical Group
HK$9.30-3.1%5.8%HK$7.0bHK$14.09PE6.7xE14.5%6.2%

1349

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$2.15-0.9%-31.3%HK$6.6bn/aPE20.2xn/a3.5%

460

Sihuan Pharmaceutical Holdings Group
HK$0.618.9%-24.7%HK$5.7bn/aPS2.8xE117.7%0%

6955

Shandong Boan Biotechnology
HK$10.242.4%-39.6%HK$5.2bHK$11.30PS7.8xS27.8%n/a

1681

Consun Pharmaceutical Group
HK$6.087.2%16.7%HK$4.8bHK$7.87PE5.7xE14.4%9.8%

2171

CARsgen Therapeutics Holdings
HK$6.1913.6%-50.0%HK$3.6bHK$7.20PB1.8xE20.4%n/a

2315

Biocytogen Pharmaceuticals (Beijing)
HK$8.785.8%-64.7%HK$3.5bHK$15.39PS4.5xE100.1%n/a

1521

Frontage Holdings
HK$1.355.5%-40.5%HK$2.7bHK$1.71PE32.3xE26.1%n/a

2256

Abbisko Cayman
HK$3.589.1%28.3%HK$2.3bHK$8.20PS112.7xE-2.3%n/a

2348

Dawnrays Pharmaceutical (Holdings)
HK$1.180.9%-11.3%HK$1.8bn/aPE5xn/a6.8%

2552

Hua Medicine (Shanghai)
HK$1.59-1.9%-46.3%HK$1.6bHK$3.13PS18.8xE83.3%n/a

1244

3D Medicines
HK$6.707.7%-90.3%HK$1.5bn/aPS2.2xn/an/a

1875

TOT BIOPHARM International
HK$1.8510.1%-16.7%HK$1.4bHK$3.80PS1.7xn/an/a

2616

CStone Pharmaceuticals
HK$1.1022.2%-65.7%HK$1.4bHK$3.45PS2.8xE56.9%n/a

1061

Essex Bio-Technology
HK$2.399.1%-34.3%HK$1.4bn/aPE4.9xn/a3.8%

1873

Viva Biotech Holdings
HK$0.6210.7%-60.0%HK$1.3bn/aPB0.3xn/an/a

2633

Jacobson Pharma
HK$0.571.8%-38.0%HK$1.1bn/aPE4.7xn/a8.6%

3737

Zhongzhi Pharmaceutical Holdings
HK$1.20-1.6%2.6%HK$1.0bn/aPE5.9xn/a5.0%

2142

HBM Holdings
HK$1.368.8%-29.9%HK$996.5mn/aPE5.6xn/an/a

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.580.6%-6.5%HK$885.2mn/aPE5.5xn/a34.2%

6628

Transcenta Holding
HK$1.811.7%-68.7%HK$735.8mHK$8.21PS12.7xE-2.4%n/a

2161

JBM (Healthcare)
HK$0.86-2.3%-21.1%HK$712.1mn/aPE7.3xn/a8.0%
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.